-----

Welcome to the February 2012 issue of Pharmaceutical Technology Sourcing and Management, your information resource about the pharmaceutical supply chain. In this issue, an analysis of value-creation strategies for biopharmaceutical companies. Plus a review of US biotechnology financing trends. And the latest developments from the bio/pharmaceutical industry relating to corporate social responsibility and sustainability.

APIs
Strategies for Value Creation in the Biopharmaceutical Industry
Patricia Van Arnum, executive editor of Pharmaceutical Technology and Pharmaceutical Technology Europe and editor of Sourcing and Management
Improving R&D productivity, life-cycle management, and operational efficiency are key approaches for enhancing growth prospects. >> Read More

Biotech
A Mixed Year for US Biotech Financing
Patricia Van Arnum, executive editor of Pharmaceutical Technology and Pharmaceutical Technology Europe and editor of Sourcing and Management.
Venture-capital financing was up last year in the US biotechnology industry, but public-equity financing, exclusive of debt, declined.
>> Read More

Outsourcing
Contract Services in 2012
Jim Miller, president of PharmSource Information Services and contributing editor to Pharmaceutical Technology
Some recent private-equity buyouts of CROs show both the upside and downside for investors.
>> Read More

CSR and Sustainability Forum
Pharmaceutical Technology’s dedicated editorial coverage on the developments in corporate social responsibility (CSR) and sustainability from the bio/pharmaceutical industry, other business sectors, and public and private organizations. This month, we feature articles on pharmaceutical companies’ activities for combating neglected tropical diseases and a roundup of CSR and sustainability news.

Pharmaceutical Companies Target Neglected Tropical Diseases
Patricia Van Arnum, executive editor of Pharmaceutical Technology and Pharmaceutical Technology Europe and editor of Sourcing and Management.
Pharmaceutical companies pledge donations of 14 billion treatments for the next decade to combat nine neglected tropical diseases. >> Read More

CSR and Sustainability in the News
A roundup of developments in corporate social responsibility and sustainability from the bio/pharmaceutical industry, its suppliers, and other public and private organizations. >> Read More

-----

Sourcing and Management’s Community of Experts
The panel consists of leading professionals involved in the synthesis, manufacture, and sourcing of active pharmaceutical ingredients and intermediates and experts in formulation and dosage-form manufacturing. The community of experts lends its expertise to the eNewsletter by providing reviews of technical articles as well as offering perspectives on topics of relevance to pharmaceutical manufacturers and their suppliers.
>> Read More

-----

For the full listing of calendar events, see the Calendar of Events page

February 2012
Feb. 14–17
Informex
New Orleans

March
Mar. 5–6
CBI's 7th Summit on Biosimilars and Follow-On Biologics
Washington, DC

March 12-15
DCAT Week
New York

April
Apr. 16–18
PDA Annual Meeting
Phoenix, AZ